The global Women’s Health Diagnostics market has been
segmented, on the basis of applications, and end users. On the basis of
application, the market is segmented into various segments, namely,
osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast
cancer testing, pregnancy & ovulation testing, prenatal genetic screening
& carrier testing, infectious disease testing, sexually transmitted disease
testing, and ultrasound.
[270 Pages Report] The women’s health diagnostics market is
projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a
CAGR of 7.9% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901
This market is mainly driven by the increased adoption of
point-of-care & rapid diagnostic tests, growth in the number of private
diagnostic centers, high prevalence of infectious diseases in women, rising
incidence of chronic & lifestyle-related disorders in women and increasing
awareness about fertility testing in women & initiatives taken by
government and health organizations.
In 2015, the breast cancer testing segment accounted for the
largest share of the market. However, the prenatal genetic screening and
carrier testing segment is expected to grow at a higher CAGR during the forecast
period. This growth can be attributed to factors such as the growing number of
doctors offering genetic screening tests to pregnant women and growing
awareness about these tests.
The breast cancer testing segment accounts for the
largest share of the market, by application, in 2019
Based on application, the women’s health diagnostics market
is divided into nine segments—osteoporosis testing, OVC testing, cervical
cancer testing, breast cancer testing, pregnancy & fertility testing,
prenatal genetic screening & carrier testing, infectious disease testing,
STD testing, and ultrasound tests. The breast cancer testing segment accounted
for the larger market share in 2019. The large share of this segment can be
attributed to the increasing incidence of breast cancer and rising awareness
about advanced breast cancer diagnostic techniques, such as ABUS.
The home care settings segment is expected to grow at the
highest CAGR during the forecast period
Based on end users, the women’s health diagnostics market is
segmented into hospitals & clinics, diagnostic & imaging centers, and
home care settings. The home care settings segment is expected to witness the
highest growth during the forecast period. The increasing advantages of using
self-testing kits will continue to drive market growth. Patient self-testing
enables patients to better manage their diseases by utilizing home/self-testing
kits. Technological advancements have made many self-testing kits available for
various conditions, such as pregnancy and ovulation.
Geographical growth scenario of Women’s Health
Diagnostics Market :
Geographically, the global market is segmented into North
America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North
America commanded the largest share of the global women health diagnostics
market. The major share of this region can be attributed to increasing
prevalence of cancer among women in this region, increasing incidence of
lifestyle related health disorders, growing focus of manufacturers of women’s
health diagnostic products on expanding their presence in this region, and increasing
demand for fertility testing monitors.
Leading market players and strategies adopted
The prominent players in this market are Siemens AG
(Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La
Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE
Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott
Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V.
(Netherlands).
Recent Developments
·
F. Hoffmann-La Roche Ltd. Launched the uPath
HER2 (4B5) Image Analysis and uPath Dual ISH Image Analysis.
·
Hologic, Inc. acquired Biotheranostics, a
privately held, commercial-stage company that provides molecular diagnostic
tests for breast and metastatic cancers, to strengthen its presence in the
women’s health diagnostics market.
·
Hologic, Inc. launched the 3DQuorum Imaging
Technology in Europe.
·
Carestream Health, Inc. opened a new global
business operations center in Mumbai, India, expanding its market presence.
Frequently Asked Questions (FAQs) :
Which are the top industry players in the global women’s
health diagnostics market?
Which global women’s health diagnostics appications have
been included in this report?
Which geographical region is dominating in the global
women’s health diagnostics market?
Which is the leading global women’s health diagnostics end
user segment?